Daiichi Seiyaku's ofloxacin
Executive Summary
Quinolone antibiotic is being developed in the U.S. by Ortho for non-ophthalmic use, not Hoechst-Roussel as was reported in the May 25 edition of "The Pink Sheet" (T&G-4). SmithKline's Allergan unit is developing ofloxacin for ophthalmic applications.